This study looked at whether low levels of vitamin D increased complications for patients with type 2 diabetes (T2D). It found that foot ulcers were more common for patients who had low vitamin D (LVD).

This study looked at the treatment of type 2 diabetes with either daily or weekly insulin injections. They found that weekly insulin was as safe and effective as daily injections.

This study looked at the risk of dementia in patients with type 2 diabetes (T2D) taking metformin (Glucophage) and those not taking this drug. They found that patients taking metformin were at a lower risk to develop dementia.

This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D).

It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients.

This study examined the role of statin (cholesterol-lowering) therapy in lowering the risk of diabetic eye disease and sight-threatening complications of diabetes. They found that patients taking a statins were less likely to suffer from advanced diabetic eye disease than those not taking a statin.  

This review looked at the effect of chromium supplements for patients with type 2 diabetes (T2D). It found that chromium supplements improved blood glucose and insulin levels for these patients.

This study looked at whether blood glucose control influenced heart disease and stroke for patients with type 2 diabetes (T2D). It found that patients with better blood glucose control had a lower risk of heart disease and stroke over the following 8 years.

This study is evaluating the effect of medically tailored meals and nutrition education via tele-health for patients with uncontrolled type 2 diabetes (T2D). The outcomes include changes in blood glucose control, body weight, and confidence in self-managing care. This study is taking place in Philadelphia, Pennsylvania, United States.

This review looked at whether metformin (Glucophage) can reduce the risk of colorectal cancer for patients with diabetes. It found that patients who had been treated with metformin may have a lower risk of colorectal cancer.

This review analysis looked at whether psyllium fiber supplements benefit patients with type 2 diabetes (T2D). It found that psyllium improves LDL cholesterol and blood sugar control for patients with T2D.